Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Monash IVF Group Ltd ( (AU:MVF) ) has issued an announcement.
Monash IVF Group Ltd has completed an Independent Review of incidents at its Brisbane and Clayton clinics, which involved non-standard IVF treatments and were unrelated. The review identified human error and IT system limitations as causes. The company has implemented many recommendations from the review and additional safeguards to prevent future occurrences, with no expected material financial impact. The company remains committed to patient care and safety.
The most recent analyst rating on (AU:MVF) stock is a Buy with a A$1.30 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Ltd is a company operating in the healthcare industry, specifically focusing on fertility services. It provides in vitro fertilization (IVF) treatments and has facilitated over 50,000 births, supporting families in their fertility journey for more than 50 years.
Average Trading Volume: 4,391,174
Technical Sentiment Signal: Sell
Current Market Cap: A$325.3M
Learn more about MVF stock on TipRanks’ Stock Analysis page.